Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil, Canada and India are some of the first countries where the patents to GLP-1 drugs expire. Keystone-SDA…
The drug-pricing problem no one wants to talk about
Some pharmaceutical companies are gaming the patent system to extend their monopoly, keeping prices high for patients. Amelie-Benoist…